These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 10379876)
1. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Taetle R; Aickin M; Yang JM; Panda L; Emerson J; Roe D; Adair L; Thompson F; Liu Y; Wisner L; Davis JR; Trent J; Alberts DS Genes Chromosomes Cancer; 1999 Jul; 25(3):290-300. PubMed ID: 10379876 [TBL] [Abstract][Full Text] [Related]
2. Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Taetle R; Aickin M; Panda L; Emerson J; Roe D; Thompson F; Davis J; Trent J; Alberts D Genes Chromosomes Cancer; 1999 May; 25(1):46-52. PubMed ID: 10221339 [TBL] [Abstract][Full Text] [Related]
3. Linksets of tumor chromosome breakpoints related to survival in ovarian adenocarcinoma. Aickin M; Taetle RM Cancer Genet Cytogenet; 2006 Apr; 166(1):22-6. PubMed ID: 16616108 [TBL] [Abstract][Full Text] [Related]
4. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis. Simon R; Desper R; Papadimitriou CH; Peng A; Alberts DS; Taetle R; Trent JM; Schäffer AA Genes Chromosomes Cancer; 2000 May; 28(1):106-20. PubMed ID: 10738309 [TBL] [Abstract][Full Text] [Related]
5. Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. Nelson MA; Radmacher MD; Simon R; Aickin M; Yang J; Panda L; Emerson J; Roe D; Adair L; Thompson F; Bangert J; Leong SP; Taetle R; Salmon S; Trent J Cancer Genet Cytogenet; 2000 Oct; 122(2):101-9. PubMed ID: 11106819 [TBL] [Abstract][Full Text] [Related]
6. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression. Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443 [TBL] [Abstract][Full Text] [Related]
7. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Panani AD; Roussos C Cancer Lett; 2006 Apr; 235(1):130-5. PubMed ID: 15927360 [TBL] [Abstract][Full Text] [Related]
8. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185 [TBL] [Abstract][Full Text] [Related]
10. Spectral karyotyping analysis of head and neck squamous cell carcinoma. Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603 [TBL] [Abstract][Full Text] [Related]
11. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
12. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Wake N; Hreshchyshyn MM; Piver SM; Matsui S; Sandberg AA Cancer Res; 1980 Dec; 40(12):4512-8. PubMed ID: 7438085 [TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Sy SM; Wong N; Lee TW; Tse G; Mok TS; Fan B; Pang E; Johnson PJ; Yim A Eur J Cancer; 2004 May; 40(7):1082-94. PubMed ID: 15093586 [TBL] [Abstract][Full Text] [Related]
14. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer? Panani AD Cancer Lett; 2007 Dec; 258(2):262-7. PubMed ID: 17945413 [TBL] [Abstract][Full Text] [Related]
15. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Kakazu N; Taniwaki M; Horiike S; Nishida K; Tatekawa T; Nagai M; Takahashi T; Akaogi T; Inazawa J; Ohki M; Abe T Genes Chromosomes Cancer; 1999 Dec; 26(4):336-45. PubMed ID: 10534769 [TBL] [Abstract][Full Text] [Related]
16. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284 [TBL] [Abstract][Full Text] [Related]
18. Chromosome abnormalities in cancer. Mitelman F; Heim S Cancer Detect Prev; 1990; 14(5):527-37. PubMed ID: 2224917 [TBL] [Abstract][Full Text] [Related]
19. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Guan XY; Cargile CB; Anzick SL; Thompson FH; Meltzer PS; Bittner ML; Taetle R; McGill JR; Trent JM Cancer Res; 1995 Aug; 55(15):3380-5. PubMed ID: 7614475 [TBL] [Abstract][Full Text] [Related]
20. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival. Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]